New Study Sponsored by Medidata Solutions Identifies Up to $5 Billion in Potential Clinical Trial Cost Savings

The results of a new research study performed by researchers at the Center for the Study of Drug Development at Tufts University School of Medicine and sponsored by Medidata Solutions found that clinical data gathered from 25 percent of the procedures administered to patients may be unnecessary – and, in the aggregate, are responsible for $3-5 billion in overall clinical trial costs annually.

Please to read the entire article.